tirzepatide vs mazdutide 📊 Research Summary: Once-weekly 9-mg led to 17% mean weight loss 2% with placebo among Chinese adults with #obesity, but most recipients reported mild or moderate gastrointestinal symptoms. #ADA2026 #ADASciSessions 🥇 Mazdutide vs Tirzepatide for

The FDA recently approved a new use for the drug, allowing it to help patients battling chronic weight management

By pairing low-dose GLP-1 medications with rigorous blood diagnostics and behavioral coaching, Noom aims to intercept metabolic dysfunction before it becomes chronic disease

You can then either stay on that new day as your permanent schedule or gradually move back to your original day over the next few weeks

10.1016/0002-9343(92)90740-3 10 SonavaneK.ShirsatP.AgrawalG.AgarwalB

It is important because it provides human biomarker-level support for the idea that GLP-1RA therapy influences redox-related physiology in parallel with its metabolic actions